SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

  • This share is currently suspended. It was suspended at a price of 0.125
  • There is currently no data for CRV

AGM Statement

15 Jun 2005 11:00

Medsea Estates Group PLC15 June 2005 Embargoed to 11.00 a.m. Wednesday 15 June 2005 Medsea Estates Group PLC AGM Statement At today's annual general meeting Mr Tony Gatehouse, Chairman, will make thefollowing statement:- "When we launched on AIM last year, we outlined our plans to maintain thesuccessful growth of Medsea. I would like to take this opportunity to highlighta number of initiatives which have been undertaken since the beginning of theyear as part of that process. - We regularly review opportunities for physical expansion in Spain and I am pleased to announce that we are about to launch our latest office in Castillon, the Costa Azahar, or in English, the Orange Blossom Coast. This is an attractive area which is under exploited and we believe it will attract significant client interest. - In April, Euromed's first product, the Frondoso Valley development in Nuevo Torre Guil, Murcia, was launched. We believe this exciting development, that will ultimately be home to almost 800 residential properties, has great potential. - Last month we announced an agreement with Barca & Boom Real Estates of the Netherlands, which has been formed to market Medsea's properties exclusively throughout Holland, Germany, Belgium and Luxembourg. - We have recently invested in two top professionals for two key areas of the Group. A dedicated financial controller has joined the team and reviewed all our procedures and controls to ensure that we are in the best shape possible to maximise our performance as the business expands. We have also appointed an in-house marketing and advertising professional who will be working with our agents to take full advantage of the opportunities available to us to expand our client numbers. - A consultancy agreement was signed in February by Euromed Investments with the propsed Arc European Property Fund. It is intended that Euromed will source suitable investment properties for the fund. "While I have been pleased with our progress, problems within the UK housingmarket and general lack of consumer confidence have had an effect on ourbusiness. As already announced, unit sales in the first quarter to March werelower than the same period of 2004. I am pleased to report that since then wehave seen some improvement in performance although overall unit sales to dateare below the comparable period. I would reiterate my comment in the annualreport that we remain confident for the longer term prospects for our business." For further information contact:Tony Gatehouse, ChairmanMedsea Estates Group PLC Today 0207 067 0700 Thereafter 0034 96 570 40 02 Juan Carlos Rodriguez Martinez, Chief ExecutiveMedsea Estates Group PLC Today 0207 067 0700 Thereafter 0034 96 570 40 02 Roland Cornish/Noelle GreenawayBeaumont Cornish Limited 0207 628 3396 Terry Garrett/ Alex WhiteWeber Shandwick Square Mile 0207 067 0700 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jul 20257:00 amRNSCancellation - Craven House Capital PLC
23rd Jun 202510:30 amRNSWithdrawl of 'Stmt re Share Price Movement' RNS
23rd Jun 202510:05 amRNSStatement re Share Price Movement
23rd Jun 20257:30 amRNSSuspension - Craven House Capital Plc
23rd Jun 20257:00 amRNSResignation of Nominated Adviser
27th Feb 20257:00 amRNSInterim Results
7th Feb 20254:22 pmRNSTR-1: Notification of major holdings
16th Dec 20242:42 pmRNSResult of AGM
15th Nov 20247:00 amRNSAnnual Results For Year Ended 31 May 2024
10th Sep 20247:00 amRNSInvestee company update: RoseMonkey Ltd
27th Aug 20247:00 amRNSTR-1: Notification of major holdings
23rd Aug 20242:19 pmRNSTR-1: notification of major holdings
5th Jun 20247:00 amRNSInvestee Companies' Update: Bio Vitos
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.